Previous Page  83 / 136 Next Page
Information
Show Menu
Previous Page 83 / 136 Next Page
Page Background

Corporate Identity Serving Diverse Industries Purpose and Values Overview by the Chairman Operational Highlights Financial Analysis Research and Technology

Safety, HealthandEnvironment Serving the Society Directors’ Report Management Discussion andAnalysis Report on Corporate Governance

Financial Statements

7 Details of raw materials consumption and goods traded in

(a) Raw materials consumption:

Particulars

2009-10

2008-09

Unit

Qty Rs crores

Qty Rs crores

Toluene

MT

14353

60.77 10136

42.15

Phenol

MT

4690

3.04

5928

37.42

Sulphur

MT

37857

18.26 22986 48.40

Methanol

MT

8414

10.51

6956

11.33

Others

569.54

504.70

Total

662.12

644.00

(b) Imported and indigenous raw materials consumption:

Category

Rs crores

% Rs crores

%

Imported

200.42

30.27 158.34

25.90

Indigenous

461.70

69.73 485.66

74.10

Total

662.12 100.00 644.00 100.00

(c) Goods traded in purchases:

Name

MT Rs crores

MT Rs crores

Dyestuffs

199

3.87

90

2.02

Intermediates

22

0.82

10

0.50

Chemical

976

8.47

524

11.74

Agro products

31,025(nos)

4.05 68,925(nos)

8.76

Total

17.20

23.03

8 Licensed and installed capacities, production, stocks and turnover

(A) Licensed and installed capacities and production:

Class of goods

Licensed capacity Installed capacity (a)

Production

2009-10 2008-09 2009-10 2008-09 2009-10 2008-09

MT

MT

MT

MT

MT

MT

Cresol

7,200 7,200 14,000 14,000 7,871 4,760

Sodium Sulphite

7,200 7,200 12,000 12,000 12,781 9,649

Gypsum

4,140 4,140 4,140 4,140 4,140

-

p

-Cresidine

420

420

420

420

340

225

p

-Anisic Aldehyde

3,600 3,600 8,400 8,400 2,636 2,660

p

-Anisic Alcohol

300

300 2,000 2,000

987

715

Manganese Sulphate

7,200 7,200 10,000 10,000 5,689 5,820

Dyestuff (b and c)

10,257 10,257 15,546 14,746 14,055 9,992

Chemicals

16,500 16,500 16,500 16,500 1,731 2,705

Sulpha drug intermediates

1,830 1,830 6,525 6,525

852 1,064

2,6-Dichloroaniline

20

20

-

-

-

-

Bulk drugs and drug intermediates

115

115

57

57

20

16

Schedule

forming part of the accounts

SCHEDULE 16 NOTES FORMING PART OF THE ACCOUNTS

(contd)